Related Experiment Video
Updated: May 5, 2026

Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection
Published on: February 28, 2021
Unique nasal cell states induced by common pediatric respiratory viruses
Jaclyn M L Walsh1,2,3,4, Lillian J Juttukonda1,4,5,6, Ying Tang1
1Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA, USA.
Insights
This study reveals how SARS-CoV-2, rhinovirus, and RSV uniquely alter the pediatric nasal lining at a cellular level. Understanding these virus-specific changes is crucial for addressing early childhood respiratory illnesses and asthma risk.
Area of Science:
- Immunology
- Virology
- Pediatric Respiratory Medicine
Background:
- Respiratory viral infections in young children cause significant illness and long-term airway problems.
- The cellular-level impact of different viruses on the pediatric nasal mucosa is not well understood.
Purpose of the Study:
- To create a detailed cellular atlas of the pediatric nasal mucosa during infections with SARS-CoV-2, rhinovirus, and respiratory syncytial virus (RSV).
- To identify virus-specific cellular responses and immune programs associated with disease severity and asthma risk.
Main Methods:
- Single-cell RNA sequencing was performed on 335,174 nasal epithelial and immune cells from 132 children under five with viral infections or uninfected.
- Viral transcripts were mapped to individual cells to identify virus-specific infected epithelial states.
- Analysis integrated asthma genome-wide association data to link cellular subsets to disease risk.
Main Results:
- Distinct virus-specific infected epithelial cell states were identified for SARS-CoV-2 (NF-kB-responsive ciliated) and RSV (KRT17+ squamous-like).
- Divergent mucosal responses included strong interferon (IFN) response in SARS-CoV-2, IL-13 secretory program in rhinovirus, and heightened inflammation in RSV.
- RSV severity was linked to specific immune subsets and IFN signatures; rhinovirus-induced wheeze correlated with CST1+ goblet cell expansion.
- A KRT13+ squamous epithelial subset was enriched for childhood-onset asthma risk loci.
Conclusions:
- This single-cell atlas provides a comprehensive view of antiviral immunity in the pediatric nasal mucosa.
- It defines virus-specific immune programs relevant to respiratory disease severity and early-life asthma risk.
- The resource facilitates high-resolution annotation of independent pediatric cohorts globally.
Abstract:
Respiratory viral infections in early childhood are major drivers of acute morbidity and long-term airway disease, yet how distinct viruses remodel the pediatric nasal mucosa at cellular resolution remains unresolved. Here, we generated a single-cell RNA sequencing atlas of 335,174 nasal epithelial and immune cells from 132 children under five years of age with SARS-CoV-2, rhinovirus, or respiratory syncytial virus (RSV) infection, alongside uninfected controls. Mapping viral transcripts to individual cells revealed virus-specific infected epithelial states: an NF-kB-responsive ciliated subset in SARS-CoV-2 and a previously undescribed KRT17+ squamous-like subset in RSV. We delineated divergent mucosal response programs, including a robust interferon (IFN) response in SARS-CoV-2, an IL-13-responsive secretory program in rhinovirus, and heightened inflammatory and cytotoxic immune activation in RSV. In RSV, specific immune subsets and elevated IFN-response signatures were associated with disease severity, whereas rhinovirus-induced wheeze was marked by expansion of a CST1+ goblet cell subset. Integration of asthma genome-wide association data with our atlas revealed a KRT13+ hillock-like squamous epithelial subset enriched for expression of childhood-onset asthma risk loci. Finally, we demonstrate that this resource enables high-resolution annotation of independent pediatric cohorts in Kolkata, India and rural Bangladesh. Together, this atlas establishes a comprehensive view of antiviral immunity in the pediatric nasal mucosa and defines virus-specific mucosal immune programs relevant to disease severity and asthma risk in early life.
More Related Videos
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Related Concept Videos
Microbiota of the Respiratory Tract
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Influenza
Anatomy of Respiratory System I: Upper Respiratory Tract
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract....
Nose and Nasal Cavity